Lesjöfors Medical division enters world-leading exhibition in Paris
First week of February, Lesjöfors exhibited for the first time at Pharmapack in Paris, the world-leading exhibition for the drug delivery devices industry.
A busy meeting spot for medical technology
Pharmapack is the European hub for the pharma packaging and drug delivery device industry. Taking place annually in Paris, the event unites over 5,000 attendees and more than 300 exhibitors for two days of innovation, networking, and education.
Many of our companies in the group have extensive knowledge in the medical device industry and this was the first time the group exhibited at Pharmapack.
Our international sales team with representatives from Lesjöfors companies in Europe, North America and Asia, displayed and discussed diverse spring solutions for medical technology in the stand. The feedback from new and existing customers was overwhelming.
Fruitful discussions in the Lesjöfors stand
Martin Schulze, Sales Manager at Lesjöfors Industrial Springs & Pressings in Germany comments on the expo participation.
“We are extremely happy with the outcome from Pharmapack. We have made many interesting contacts and got a good chance to listen to what the industry is talking about, both opportunities and challenges. Lesjöfors is here to help with our outstanding medical springs and pressings as well as deep knowledge in manufacturing.”
Sofia Håkansson
Marketing and Communications Director
+46 54 13 77 56
sofia.hakansson@lesjoforsab.com
The Lesjöfors Group provides the widest range of springs and pressings to customers in diverse industries across the world. With a unique expertise in high technological, custom-made solutions and a flexible manufacturing capacity, Lesjöfors is the premier partner for all spring requirements. Lesjöfors, owned by Beijer Alma a listed company on the Stockholm Stock Exchange, comprises almost 50 manufacturing and sales companies in many countries. As a long-term and committed spring innovator, the Group continuously grows with a good profitability, both organically and by acquisitions.
